Poland· PL-100483139
Bekemv
A l04aj01, l04aa25 product containing eculizumabum, registered in Poland by Amgen Technology (Ireland) UC.
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Eculizumabum
- Manufacturer
- Amgen Technology (Ireland) UC
- Country
- Poland (PL)
- ATC code
- L04AJ01, L04AA25
- ATC class
- L04AJ01, L04AA25
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin08715131025755
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Eculizumabum in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumBekemv 300 mgAmgen Europe
- CzechiaBEKEMVAmgen Europe B.V., Breda
- FinlandBEKEMVAmgen Europe B.V.
- IrelandBEKEMV 300 mg Concentrate for solution for infusionAmgen Technology (Ireland) Unlimited Company
- IcelandBekemvAmgen Technology (Ireland) UC*
- NorwayBekemvAmgen Technology Ireland
- SwedenBEKEMV 300 mg Koncentrat till infusionsvätska, lösningAmgen Europe B.V.
- United StatesBKEMVAmgen Inc
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Bekemv, Soliris
- Liechtenstein · Soliris
- Norway · Bekemv, Soliris
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/44f96803-f09b-4bcf-9478-8ea35f972139 GET /v1/drugs/44f96803-f09b-4bcf-9478-8ea35f972139?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Koncentrat do sporządzania roztworu do infuzji",
"source": "urpl",
"strength": "300 mg",
"packaging": "08715131025755 ¦ Rpz ¦ EU/1/23/1727/001 ¦ 150080\n1 fiol. 30 ml",
"substance": "Eculizumabum 300 mg",
"common_name": "Eculizumabum",
"pl_product_id": "100483139",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about eculizumabum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.